Earnings
SPPI
3.070
-3.76%
-0.120
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
46.01M
134.02M
--
67.00K
--
--
2.39M
--
--
--
2.17M
2.00M
186.65M
5.82M
--
--
--
--
--
--
4.33M
10.15M
196.80M
--
34.38M
0.00
--
--
--
43.77M
--
13.48M
--
--
--
5.28M
53.15M
0.00
--
--
--
9.41M
9.41M
62.55M
146.00K
1.02B
-885.29M
--
--
--
134.24M
134.24M
196.80M
FY 2019-12-31
64.42M
159.46M
--
441.00K
--
--
9.56M
--
--
--
1.41M
8.74M
244.02M
15.41M
334.00K
--
--
--
--
--
3.67M
19.41M
263.43M
--
32.01M
0.00
--
--
--
6000.00
--
13.50M
--
--
--
16.46M
61.97M
0.00
--
--
0.00
11.07M
11.07M
73.04M
113.00K
918.21M
-724.43M
--
--
--
190.39M
190.39M
263.43M
FY 2018-12-31
157.48M
46.51M
--
29.87M
--
--
3.70M
--
3.55M
--
782.00K
12.35M
250.69M
385.00K
668.00K
0.00
--
18.06M
111.59M
--
139.15M
140.20M
390.89M
--
44.92M
0.00
--
--
--
296.00K
--
26.70M
--
--
--
26.70M
98.33M
0.00
--
--
1.47M
19.68M
21.15M
119.48M
110.00K
886.74M
-611.74M
--
--
--
271.41M
271.41M
390.89M
FY 2017-12-31
227.32M
248.00K
--
32.26M
--
--
2.13M
--
5.71M
--
4.03M
6.03M
277.75M
589.00K
2.19M
37.53M
--
18.16M
137.16M
--
14.07M
209.69M
487.44M
--
33.65M
38.22M
--
--
--
296.00K
--
27.32M
--
--
--
10.56M
109.75M
0.00
--
--
1.44M
24.91M
26.35M
136.10M
100.00K
837.35M
-502.11M
--
--
--
351.34M
351.34M
487.44M
FY 2016-12-31
158.22M
247.00K
--
39.78M
--
--
5.75M
--
8.71M
--
3.93M
--
216.65M
449.00K
1.51M
11.53M
--
17.89M
164.23M
--
16.51M
212.12M
428.77M
--
30.49M
0.00
--
--
--
384.00K
--
27.20M
--
--
--
7.83M
65.51M
97.04M
--
--
6.67M
23.51M
127.23M
192.74M
80.00K
640.17M
-402.64M
--
--
--
236.03M
236.03M
428.77M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out SPPI latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Spectrum Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.